Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
943.90
23.1 (2.51%)
BSENSE

Feb 03

BSE+NSE Vol: 61.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Granules India
Alivus Life
Sanofi India
Caplin Point Lab
Sanofi Consumer
P & G Health Ltd
Cohance Life
Concord Biotech
Corona Remedies
OneSource Speci.
Rubicon Research
Why is Alivus Life Sciences Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 4.84% and Operating profit at 2.21% over the last 5 years
2
Flat results in Sep 25
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 19.18 cr
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.39% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -20.15% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Alivus Life should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Alivus Life for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Alivus Life
-19.67%
-0.54
37.44%
Sensex
8.49%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.88%
EBIT Growth (5y)
4.00%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
1.10
Tax Ratio
25.19%
Dividend Payout Ratio
58.54%
Pledged Shares
0
Institutional Holding
12.21%
ROCE (avg)
37.18%
ROE (avg)
18.73%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
21
Industry P/E
32
Price to Book Value
3.84
EV to EBIT
15.48
EV to EBITDA
14.07
EV to Capital Employed
4.54
EV to Sales
4.38
PEG Ratio
0.75
Dividend Yield
0.53%
ROCE (Latest)
27.80%
ROE (Latest)
18.68%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(Q)

Highest at Rs 672.89 cr

PBDIT(Q)

Highest at Rs 231.28 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 34.37%

PBT LESS OI(Q)

Highest at Rs 210.12 cr.

PAT(Q)

Highest at Rs 169.69 cr.

EPS(Q)

Highest at Rs 12.25

-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 19.18 cr

Loading Valuation Snapshot...
Here's what is working for Alivus Life
Net Sales - Quarterly
Highest at Rs 672.89 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 231.28 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 34.37%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 210.12 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 210.12 cr has Grown at 25.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 167.33 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 169.69 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 169.69 cr has Grown at 28.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 132.60 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 12.25
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Alivus Life
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 19.18 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents